Skip to main content

Israel stocks steady; Teva beats estimates

Israel stocks are steady to higher Tuesday, reflecting weakness in the banks and telecom provider Bezeq, but offset by gains in Israel Chemicals and in Teva Pharmaceutical, which beats analyst estimates with its second-quarter earnings.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.